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 STUDY HIGHLIGHTS 
WHAT IS CURRENT KNOWLEDGE 
 Gastroesophageal reflux symptoms (GERS) can severely affect health related quality 
of life. 
 GERS are highly prevalent and the prevalence is still increasing. 
 High body mass index (BMI) is associated with prevalent GERS. 
 
WHAT IS NEW HERE 
 Gain in BMI was associated with new-onset GERS, independent of BMI at baseline. 
Higher gain in BMI was associated with increasing risk of new-onset GERS. 
 Ever having smoked tobacco was associated with new-onset GERS. 
 Tobacco smoking cessation was associated with new-onset GERS among those who 
gained weight upon quitting. 
 Increasing age and lower education was associated with new-onset GERS. 
 ABSTRACT (Word count 249) 
OBJECTIVES: 
Gastroesophageal reflux disease (GERD) is a highly prevalent disorder. This study assessed 
risk factors of new-onset gastroesophageal reflux symptoms (GERS). 
 
METHODS: 
The study was based on the HUNT study, a prospective population-based cohort study 
conducted in 1995–1997 and 2006–2009 in Nord-Trøndelag County, Norway. All inhabitants 
from 20 years of age were invited. Risk factors of new-onset heartburn or acid regurgitation 
were examined using logistic regression, providing odds ratios (OR) and 95% confidence 
intervals (CI). 
 
RESULTS: 
29,610 individuals were included (61% response rate). Participants reporting no GERS at 
baseline and severe GERS at follow-up (new-onset GERS; n=510) were compared to 
participants reporting no complaints at both times (n=14,406). Increasing age (OR 1.01 per 
year, 95%CI 1.00–1.02) was positively whereas male sex (OR 0.81, 95% CI 0.66-0.98) and 
higher education (OR 0.69, 95%CI 0.56–0.86) were negatively associated with new-onset 
GERS. Gain in body mass index (BMI) was dose-dependently associated with new-onset GERS 
(OR 1.30 per unit increase in BMI, 95%CI 1.25–1.35), irrespective of baseline BMI. Previous 
and current tobacco smoking were associated with new-onset GERS (OR 1.37, 95%CI 1.07-
1.76 and OR 1.29, 95%CI 1.00-1.67, respectively). Tobacco smoking cessation was associated 
with new-onset GERS among those with gain in BMI upon quitting (OR 2.03, 95% CI 1.31-
3.16, with >3.5 BMI units increase). 
  
CONCLUSIONS: 
New-onset GERS were associated with increasing age, female sex, lower education, gain in 
BMI and ever tobacco smoking. Tobacco smoking cessation was associated with new-onset 
GERS among those who gained weight upon quitting.  
 INTRODUCTION 
Gastroesophageal reflux disease (GERD) is defined according to the Montreal classification 
as “a condition that develops when reflux of stomach contents causes troublesome 
symptoms and/or complications. (…) In population-based studies, mild symptoms occurring 
two or more days a week, or moderate/severe symptoms occurring more than one day a 
week, are often considered troublesome by patients” (1). GERD is highly prevalent in the 
Western world and the prevalence is still increasing (2). The treatment can be long lasting, 
the health expenses high, and the disease affects health related quality of life (3). Several 
studies have investigated prevalent gastroesophageal reflux symptoms (GERS) and related 
risk factors (4). Only a few studies have investigated risk factors on the development of new-
onset GERS (3,5). Knowledge on the risk factors of new-onset GERS is important upon 
identifying persons at risk and giving evidence-based recommendations about preventive 
lifestyle changes The aim of this study was to investigate the risk factors of new-onset GERS 
in a large population-based cohort followed prospectively over time. 
 METHODS 
Study population 
Nord-Trøndelag County, Norway, comprises approximately 135,000 inhabitants, and its 
residents are representative for the Norwegian population as a whole (7). The Nord-
Trøndelag Health Study (HUNT) has been conducted in three consecutive surveys: HUNT1 
(1984–86), HUNT2 (1995–97), and HUNT3 (2006–08). All inhabitants from 20 years of age 
were invited by mail. GERS were assessed in the two latter surveys. The surveys consisted of 
extensive questionnaires, clinical measurements, and blood samples (8). Subsequent 
HUNT3, non-participants were sent a mini-questionnaire (Mini-Q) by mail. Mini-Q assessed 
GERS as well as other health related topics. Those who participated in HUNT2 and were 
followed up in HUNT3 or Mini-Q were included in the present study (6).  
 
Assessment of reflux symptoms 
Participants in HUNT2 and HUNT3/Mini-Q were asked; “to what degree have you had 
heartburn or acid regurgitation during the previous 12 months?” followed by the response 
alternatives “no complaints”, “minor complaints” or “severe complaints”. Participants 
reporting no complaints in HUNT2 and severe complaints in HUNT3/Mini-Q were defined as 
having new-onset GERS, and compared to participants reporting no complaints in both 
HUNT2 and HUNT3/Mini-Q. Those reporting minor complaints in HUNT3/Mini-Q were 
excluded. 
 
Assessment of body mass index 
Trained personnel objectively measured weight and height of the participants in HUNT2 and 
HUNT3. In Mini-Q weight and height were self-reported. Body mass index (BMI) equals 
 weight in kilograms divided by height in meters squared (kg/m2). Change in BMI was 
calculated as the difference in BMI between HUNT2 and HUNT3/Mini-Q and categorized into 
the groups: >0.5 units decrease, <0.5 units change (reference group), 0.5–1.5 units increase, 
>1.5–3.5 units increase, and >3.5 units increase. Based on the World Health Organization’s 
classification for BMI; participants were stratified by normal weight (BMI <25.0), pre-obesity 
(BMI 25.0–29.9), and obesity (BMI ≥30.0) (9). 
 
Assessment of tobacco smoking 
In HUNT2 participants were asked “do you smoke?” followed by the response alternatives 
“never”, “previous”, or “daily”. Participants in HUNT3/Mini-Q were asked “do you smoke?” 
followed by the alternatives “never”, “previous”, “occasionally”, or “daily”. Based on the 
answer in both surveys, smoking status was categorized into the following groups: Never 
smokers (“never” in both HUNT2 and HUNT3/Mini-Q); previous smokers (“previous” in both 
HUNT2 and HUNT3/Mini-Q, or “previous” in HUNT2 and “never” in HUNT3/Mini-Q); quitters 
(“never” in HUNT2 and “previous” in HUNT3/Mini-Q, or “daily” in HUNT2 and “previous” in 
HUNT3/Mini-Q, or “daily” in HUNT2 and “never” in HUNT3/Mini-Q); and current smokers 
(“occasionally” and “daily” in HUNT3/Mini-Q). Ever smokers were defined as previous 
smokers, quitters or current smokers. 
 
Assessment of additional covariables 
All additional covariables used were assessed in HUNT3/Mini-Q with the exception of 
education, which was assessed in HUNT2. The additional covariables were chosen due to 
their potential of confounding (10). These variables were age, sex, alcohol consumption, 
frequency of physical exercise, and education. The participants reported their frequency of 
 alcohol drinking during the past 12 months and their frequency of physical exercise. The 
variables were dichotomized into ≤weekly or >weekly alcohol consumption and <weekly or 
≥weekly physical exercise. The participants reported their highest level of education based 
on old or new educational systems in Norway, whichever relevant. For simplicity, as these 
levels of education also can be translated into years of education, we dichotomized 
education into low (≤12 years) or high (>12 years).  
 
Statistical analyses 
To assess differences between those reporting no GERS and those reporting new-onset 
GERS, χ2 test for categorical data and Mann-Whitney U-test for continuous data were 
employed. Associations between the risk factors and new-onset GERS were explored using 
univariable and multivariable logistic regression analyses, expressed as odds ratios (ORs) 
with 95% confidence intervals (95% CIs). Multivariable logistic regression models were 
tested for interactions, and based on these analyses the models were stratified by sex and 
age. A margins plot of predicted probabilities was drawn to investigate the association 
between age and education on the development of severe GERS. Based on this margins plot, 
age of 65 was set as cut-off for age strata. To estimate the proportion of severe GERS in the 
population attributable to change in BMI, we calculated the population attributable fraction 
(PAF) (11,12). The PAF was calculated according to the following formula: 
PAF%	=	100´
p
ex
(OR-1)
p
ex
(OR-1)+1
, where pex represented the prevalence of the exposure (change in 
BMI) in the population under study and OR the adjusted OR of the risk factor. Individuals 
with missing data were left out from the analyses. Hosmer-Lemeshow test for goodness of 
 fit was applied on all regression models. All analyses were performed using Stata Statistical 
Software: Release 13. College Station, TX: StataCorp LP.  
 
Study Approval 
This study was approved by “The Regional Committee for Medical and Health Research 
Ethics, Central Norway” (ID: 2012/1290 4.2009.328). All participants signed a written 
consent. 
 RESULTS 
Participation 
The participation has previously been reported in detail (13). To summarize, in HUNT2 
(1995–97) and HUNT3/Mini-Q (2006–09), 58,864 (64% response rate) and 44,997 (49% 
response rate) individuals reported their degree of GERS, respectively. Among these 29,610 
individuals participated in both surveys, corresponding to 61% successfully followed up, 
after excluding 10,535 participants who had died or were no longer resident in the county at 
the time of HUNT3/Mini-Q (non-eligible for follow-up). Mean follow-up time was 
approximately 11 years. When comparing participants successfully followed up in 
HUNT3/Mini-Q to all participants in HUNT2 the former group was characterized by lower 
age, more women, fewer smokers, a lower proportion who did not exercise weekly, and 
higher education (6). There were no differences in GERS, BMI, or alcohol consumption. Of 
the 20,310 participants reporting no complaints in HUNT2, 510 reported severe complaints 
(new-onset GERS) in HUNT3/Mini-Q and 14,406 reported no complaints (figure 1). 
Individuals reporting new-onset GERS at follow-up were more likely to be women, have 
higher BMI, being ever smokers, doing less physical exercise, and have lower education, than 
individuals reporting no complaints in HUNT3/Mini-Q (table 1). Women had higher increase 
in BMI during follow-up than men (mean 1.14 and 0.99, respectively), and more women than 
men had weight gain of 1.5–3.5 BMI units (41.3% vs. 36.9%) and >3.5 BMI units (14.2% vs. 
8.5%). 
 
Main analysis 
New-onset GERS was negatively associated with male sex and higher education; whereas, it 
was positively associated with increasing age, increase in BMI during follow-up and ever 
 smoking (table 2). More than weekly physical exercise was negatively associated with new-
onset GERS in the univariable analysis, but the association was not maintained after 
adjustments for the other variables (table 2). Alcohol consumption did not show any 
association with new-onset GERS (table 2). 
 
Sub-analysis: body mass index 
A dose-response relationship between increasing BMI categories and risk of new-onset GERS 
was demonstrated (p for trend <0.001; figure 2a). Adjusted OR for new-onset GERS was 1.77 
(95%CI 1.28-2.45) and 4.91 (95%CI 3.54-6.81) among those with an increase in BMI >1.5–3.5 
and >3.5 units, respectively (figure 2a). PAF was estimated to be -5.9% among participants 
with ≥0.5 units decrease in BMI, 6.9% among those having 0.5–1.5 units increase, 17.6% 
among those having >1.5–3.5 units increase, and 31.8% among those having >3.5 units 
increase. 
When stratifying by BMI at HUNT2, a BMI increase of >3.5 units in the normal weight group 
(BMI<25.0) and a BMI increase of >1.5–3.5 or >3.5 units in the pre-obese group (BMI 25.0-
29.9) were associated with new-onset GERS (figure 2b and 2c). In the obese group (BMI ≥30) 
a similar trend was observed (figure 2d). There was a dose-response relationship between 
increasing BMI and the risk of new-onset GERS in all strata (p for trend ≤0.003).  
The adjusted OR of new-onset GERS per unit increase in BMI at HUNT3/Mini-Q was 1.10 
(95% CI 1.08–1.12). 
 
Sub-analysis: tobacco smoking  
In analyses stratified by tobacco smoking status, change in BMI between HUNT2 and 
HUNT3/Mini-Q had no substantial influence on the risk of new-onset GERS in previous 
 smokers (quitting smoking before baseline in HUNT2) or current smokers (figure 3a and 3c). 
However, smoking cessation (quitting smoking between baseline in HUNT2 and follow-up in 
HUNT3/Mini-Q) was associated with new-onset GERS among those with >1.5-3.5 and >3.5 
units increase in BMI (OR 1.71, 95% CI 1.04-2.79 and OR 2.03, 95% CI 1.31-3.16, respectively; 
figure 3b).  Those exposed to smoking cessation and >3.5 units increase in BMI, had a lower 
BMI at baseline than never smokers (mean 25.0 and 26.1, respectively), but had a higher 
mean BMI increase than the never smokers (mean 5.15 and 4.98, respectively). 
 
Sub-analysis: education, sex and age 
Education interacted with age and sex. There was a stronger association between new-onset 
GERS and low education among the younger participants (<65 years) than the older 
participants (≥65 years), and among women than men (supplementary figure 1).  
Increasing age was positively associated with new-onset GERS for both sexes <65 years, but 
there was no such association in the group ≥65 years (supplementary table 1). Increase in 
BMI was associated with new-onset GERS for both sexes and all ages, except for men ≥65 
years (supplementary table 1). For men of ≥65 years 4.2% (n=75) had a gain in BMI >3.5 
units, which was low compared to women of ≥65 years (7.3% [n=139]). 
 DISCUSSION 
In this population-based prospective cohort study with approximately 11 years follow-up 
there was a dose-dependent association between gain in BMI and new-onset GERS, 
irrespective of the participant’s BMI at baseline. Ever smoking was positively associated with 
new-onset GERS. Smoking cessation was also positively associated with new-onset GERS, 
however, only in those who gained BMI upon quitting. Women had increased risk of new-
onset GERS compared to men. The risk of new-onset GERS increased with lower level of 
education and increasing age. 
The population-based design and the large study sample are major strengths of this study 
that increases power, decreases risk of chance findings, helps diminish selection bias, and 
facilitate subgroup analyses. The prospective design minimizes recall bias. The population of 
Nord-Trøndelag County is a stable population which is representative of the Norwegian 
population at large, with the exceptions of a slightly lower average income and absence of a 
large city (7,14). 
One weakness of this study is that it was conducted before the Montreal consensus and did 
not utilize the definition (1). However, the Montreal definition states that “moderate/severe 
symptoms occurring more than one day a week, are often considered troublesome by 
patients” and in a validation study succeeding HUNT2 and in the Mini-Q, 95 and 98% of the 
participants who reported severe GERS stated “at least weekly symptoms”, respectively (15). 
Thus, most participants in this study meet the Montreal criteria. Participants reporting minor 
complaints were left out of all analyses, because their complaints represented sporadic, less 
than weekly symptoms in 75 and 69%, respectively (13,15). To better identify participants 
with symptoms caused by reflux, rather than non-specific complaints, a definition of 
 heartburn and acid regurgitation could have been explained to the participants. Thus, some 
participants reporting GERS in this study might not have true GERD. 
Self-measured height and weight in Mini-Q (n=1,696 [11.3%]) is a limitation of this study 
introducing potential information bias and underreporting of gain in BMI (16). However, this 
will result in an underestimation of the association between gain in BMI and new-onset 
GERS, attenuating the positive association. 
The Norwegian Prescription Database was established in 2004 and the participant’s 
consumption of anti-reflux medication in HUNT2 could not be assessed. Thus, some 
individuals with GERD could have been categorized as having no GERS at baseline due to 
treatment. However, studies have found that among patients with GERS, 63.4% report 
current symptoms and 72% report recent symptoms despite being on anti-reflux 
medications (17,18). This held together with the fact that many patients with GERD are 
instructed in an intermittent on-demand treatment regime based on symptoms and the 
questionnaire’s 12 months recall period, indicates that the majority of participants with 
prevalent GERS would have reported minor or severe GERS at HUNT2. 
Information on education was obtained in HUNT2 and was not assessed in HUNT3/Mini-Q. 
Earlier findings on socioeconomic status (SES) and GERS from HUNT1 and HUNT2, indicate 
that there should not be any difference on whether this information is collected in HUNT2 or 
HUNT3/Mini-Q (19). 
Non-participation in HUNT3 has been validated, and was associated with high age, male sex, 
low SES, and chronic diseases (20). It is reasonable to assume that the same differences 
were present at inclusion in HUNT2. In our study, those participating in HUNT2 had 
essentially similar demographic and baseline characteristics as those successfully followed 
 up in HUNT3/Mini-Q. After excluding those participants who had died or moved from the 
county, 61% was successfully followed up, which is considered adequate (21). 
One could propose that if the whole background population were included in HUNT2 and 
followed up successfully, more individuals of old age, smokers, and low education would 
have participated, making stronger estimates with more narrow confidence intervals 
possible (20,22). Especially for the oldest participants, more precise estimates could have 
been made. In the multivariable analyses, 989 (6.6%) of the participants had missing values. 
Because this relatively low number, no further corrections was made to assess missing 
values, assuming no substantial influence on the results. In HUNT2 and HUNT3/Mini-Q, 570 
and 237 participants reported to be pregnant, respectively. This study did not assess 
pregnancy. However, pregnancy did not change the cumulative incidence of GERS in this 
study population (13). We cannot rule out residual confounding due to unmeasured factors. 
To our knowledge, only one Danish and one UK study have assessed risk factors on 
development of new-onset GERS (3,5). The Danish study comprised participants of 40–65 
years of age, and found new-onset GERS to be associated with high BMI at follow-up, low 
education, and consumption of antacids. The UK study comprised participants of 50–59 
years of age and had a low follow-up rate (40.7%), but found new-onset GERS to be 
associated with high BMI at follow-up and low quality of life at baseline.  
The present study suggests a dose response relationship between gain in BMI and new-
onset GERS, independent of the participants BMI at baseline. No study has earlier described 
such an association. PAFs calculated in this study suggest that gain in BMI, especially >3.5 
units increase, attributes to a large proportion of the cases with new-onset GERS. 
In agreement with previous studies, the present study found no association between new-
onset GERS and alcohol consumption. We note that alcohol consumption in this study was 
 lower than in the two other studies, representing the consumption in the Norwegian 
population (23). 
Several population-based studies have found a positive association with tobacco smoking 
and prevalent GERS (4). Our study confirms the association with new-onset GERS. The 
present study also demonstrated a relationship between tobacco smoking cessation and 
new-onset GERS, which corresponds to an earlier finding assessing previous smokers (24). 
However, when stratifying for gain in BMI during follow-up, these participants had a notably 
higher gain in BMI compared to the other participants. This probably explains the association 
between tobacco smoking cessation and new-onset GERS, and corresponds to earlier 
findings on smoking cessation and substantial weight gain (25). This implies that weight gain 
must be avoided if smoking cessation should be effective as a lifestyle treatment of GERS, 
previously shown in the HUNT study (26). 
Unlike the Danish and UK studies, we found a slight association with age on new-onset GERS 
(OR 1.01 per year, 95%CI 1.00–1.02). The association is of minor importance from year to 
year, but over decades the association gets more important. Age showed association with 
new-onset GERS in participants <65 years, but no association with age was found in 
participants ≥65 years of age. The number of participants in the strata of women ≥65 years 
and men ≥65 years and was low (n=1,632 and n=1,656, respectively), and this reduces power 
to detect minor associations. Anyhow, these findings corresponds to an earlier study where 
age was not associated with new-onset GERS in participants >69 years of age (24). The 
reason for not finding any association between gain in BMI on new-onset GERS among men 
≥65 years seems to be due to the low number of individuals along with few participants with 
a substantial gain in BMI compared to the three other strata. 
 Difference between the sexes found in our study seems to be due to a higher weight gain 
among women than men. Also, more men had prevalent reflux in HUNT2 and thereby were 
excluded from the present study (13). The present study suggests that education as a 
measure of SES has varying influence on new-onset GERS on the wide age span of this study 
sample. In the population <65 years of age, low level of education was associated with new-
onset GERS among women and the same trend was seen for men. However, there was no 
such association between new-onset GERS in the population ≥65 years. In the population 
≥65 years, higher education was less common and thus education is a suboptimal measure 
of SES in this subpopulation. 
 
 CONCLUSION 
In this large prospective population-based cohort study increasing age, female sex, increase 
in BMI, ever tobacco smoking, and low level of education were associated with new-onset 
GERS. Because of an increase in BMI after smoking cessation, new-onset GERS was 
associated with smoking cessation as well. Weight gain attributed to a considerable part of 
new cases of GERS, independent of weight at baseline. Our findings enhance that avoiding 
weight gain is an important preventive measure of GERS.
 ACKNOWLEDGEMENTS 
The Nord-Trøndelag Health Study (The HUNT Study) is a collaboration between HUNT 
Research Centre (Faculty of Medicine, Norwegian University of Science and Technology 
NTNU), Nord-Trøndelag County Council, Central Norway Health Authority, and the 
Norwegian Institute of Public Health 
 
CONFLICT OF INTEREST 
Guarantor of the article: Andreas Hallan, BSc Med. 
Specific author contributions: A.H., M.B., J.M.-H., and E.N.-J. have provided substantial 
contributions in planning and conducting the study, interpreting data, drafting manuscript, 
and have approved the final draft submitted; K.H. has provided substantial contributions in 
planning and conducting the study, collecting and interpreting the data, drafting the 
manuscript, and he has approved the final draft. 
Financial support: A.H. received support from the Letterstedtska Föreningen, an 
organization supporting Nordic collaboration by appointment by the Swedish State. The 
funding and supporting organization had no role in the study design, collection, analysis, or 
interpretation of the data or in the writing of the report.  
Potential competing interests: None.
 REFERENCES 
1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of 
gastroesophageal reflux disease: a global evidence-based consensus. 2006. p. 1900–
20– quiz 1943. 
2. El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-
oesophageal reflux disease: a systematic review. Gut 2014;63:871–880. 
3. Hansen JM, Wildner-Christensen M, Schaffalitzky de Muckadell OB. Gastroesophageal 
reflux symptoms in a Danish population: a prospective follow-up analysis of 
symptoms, quality of life, and health-care use. Am. J. Gastroenterol. 2009;104:2394–
2403. 
4. Dent J, El-Serag HB, Wallander M-A, et al. Epidemiology of gastro-oesophageal reflux 
disease: a systematic review. Gut 2005;54:710–717. 
5. Ford AC, Forman D, Bailey AG, et al. The natural history of gastro-oesophageal reflux 
symptoms in the community and its effects on survival: a longitudinal 10-year follow-
up study. Aliment. Pharmacol. Ther. 2013;37:323–331. 
6. Ness-Jensen E, Lindam A, Lagergren J, et al. Weight Loss and Reduction in 
Gastroesophageal Reflux. A Prospective Population-Based Cohort Study: The HUNT 
Study. Am. J. Gastroenterol. 2013;108:376–382. 
7. Holmen J, Midthjell K, Krüger Ø, et al. The Nord-Trøndelag Health Study 1995–97 
(HUNT 2): objectives, contents, methods and participation. Norsk epidemiologi 
2003;13:19–32. 
 8. Krokstad S, Langhammer A, Hveem K, et al. Cohort Profile: the HUNT Study, Norway. 
Int J Epidemiol 2013;42:968–977. 
9. WHO Consultation on Obesity. Part 1. In: Obesity: preventing and managing the global 
epidemic. Report of a WHO consultation. World Health Organization; 2000. p. 5–37. 
10. Rothman KJ, Greenland S, Lash TL. Chapter 9. In: Modern Epidemiology. Lippincott 
Williams & Wilkins; 2008. p. 129–147. 
11. Santos Silva dos I. Chapter 16. In: Cancer Epidemiology. International Agency for 
Research on Cancer; World Health Organization; 1999. p. 355–383. 
12. Zhang J, Kai FY. What's the relative risk?: A method of correcting the odds ratio in 
cohort studies of common outcomes. JAMA 1998;280:1690–1691. 
13. Ness-Jensen E, Lindam A, Lagergren J, et al. Changes in prevalence, incidence and 
spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-
based cohort study, the HUNT study. Gut 2012;61:1390–1397. 
14. Statistical yearbook of Norway 2010. Statistics Norway: Akademika; 2010.  
15. Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for 
gastroesophageal reflux symptoms. JAMA 2003;290:66–72. 
16. Krul AJ, Daanen HAM, Choi H. Self-reported and measured weight, height and body 
mass index (BMI) in Italy, the Netherlands and North America. Eur J Public Health 
2011;21:414–419. 
17. Reimer C, Bytzer P. Perceptions and Beliefs concerning Gastroesophageal Reflux 
 Disease: Physicians and Patients Disagree. Digestion 2007;76:229–234. 
18. Jones R, Armstrong D, Malfertheiner P, et al. Does the treatment of gastroesophageal 
reflux disease (GERD) meet patients’ needs? A survey‐based study. Current Medical 
Research and Opinion 2006;22:657–662. 
19. Jansson C, Nordenstedt H, Johansson S, et al. Relation between gastroesophageal 
reflux symptoms and socioeconomic factors: a population-based study (the HUNT 
Study). Clin. Gastroenterol. Hepatol. 2007;5:1029–1034. 
20. Langhammer A, Krokstad S, Romundstad P, et al. The HUNT study: participation is 
associated with survival and depends on socioeconomic status, diseases and 
symptoms. BMC Med Res Methodol 2012;12:143. 
21. Rothman KJ, Greenland S, Lash TL. Chapter 7. In: Modern Epidemiology. Lippincott 
Williams & Wilkins; 2008. p. 101–110. 
22. Winding TN, Andersen JH, Labriola M, et al. Initial non-participation and loss to follow-
up in a Danish youth cohort: implications for relative risk estimates. J Epidemiol 
Community Health 2014;68:137–144. 
23. OECD, European Union. Health at a Glance: Europe 2010. OECD Publishing; 2010.  
24. Ruigómez A, Rodríguez LAG, Wallander M-A, et al. Natural history of gastro-
oesophageal reflux disease diagnosed in general practice. Aliment. Pharmacol. Ther. 
2004;20:751–760. 
25. Aubin H-J, Farley A, Lycett D, et al. Weight gain in smokers after quitting cigarettes: 
meta-analysis. BMJ 2012;345:e4439. 
 26. Ness-Jensen E, Lindam A, Lagergren J, et al. Tobacco smoking cessation and improved 
gastroesophageal reflux: a prospective population-based cohort study: the HUNT 
study. Am. J. Gastroenterol. 2014;109:171–177. 
 FIGURE LEGENDS  
Figure 1. Participants for the assessment of new-onset GERS; GERS, gastroesephageal reflux 
symptoms; HUNT, Nord-Trøndelag Health Study. 
 
Figure 2. Odds ratios (OR) with 95% confidence intervals (95% CI) for development of new-
onset gastroesophageal reflux symptoms (GERS) by change in body mass index (BMI) during 
follow-up HUNT2–HUNT3/Mini-Q, stratified by weight at baseline HUNT2; adjusted for age, 
sex, tobacco smoking, alcohol consumption, physical exercise, and education. 
 
Figure 3. Odds ratios (OR) with 95% confidence intervals (95% CI) for development of new-
onset gastroesophageal reflux symptoms (GERS) by change in body mass index (BMI) during 
follow-up HUNT2–HUNT3/Mini-Q, stratified by tobacco smoking status ; adjusted for age, 
sex, alcohol consumption, physical exercise, and education. 
